Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GRDNthis companyGuardian Pharmacy Services, Inc.	$43.35	38.09×	9.12×	1.3×	19.17×	-43.2%	19.5%	6.1%	3.4%	23.9%	22.9%	4.3%	0.18×	-0.3×	133.71×	1.38×	0.0%	6	12.8	3	B+
EWTXEdgewise Therapeutics, Inc.	$45.72	-15.23×	4.89×	0×	-15.09×	-98.7%	0.0%	0.0%	0.0%	-32.1%	-36.4%	-5.6%	0.01×	0.35×	0×	19.85×	0.0%	1	75.67	2	C
JANXJanux Therapeutics, Inc.	$14.14	-7.54×	0.89×	85.51×	-7.39×	-118.0%	79.7%	-1576.7%	-1136.3%	-11.9%	-16.0%	-9.7%	0.02×	0.27×	0×	39.04×	0.0%	3	8.27	2	C+
MDPediatrix Medical Group, Inc.	$31.42	11.03×	2.11×	0.95×	7.69×	-20.8%	24.7%	12.1%	8.6%	19.1%	9.7%	13.9%	0.76×	1.04×	6.43×	1.66×	0.0%	7	2.44	3	B+
NHCNational HealthCare Corporation	$211.75	17.67×	1.98×	1.4×	9.81×	-20.4%	39.3%	8.5%	7.9%	11.2%	7.4%	7.0%	0.08×	-0.11×	20.15×	1.77×	1.8%	8	7.27	4	A-
NUVBNuvation Bio Inc.	$4.27	-14.93×	10.01×	48.65×	-15.36×	-33.1%	86.6%	-338.7%	-325.3%	-66.9%	-41.0%	-5.7%	0.03×	0.81×	-15.57×	6.95×	0.0%	3	0.52	1	C-
Peer median	—	-7.54×	2.11×	1.4×	-7.39×	-33.1%	39.3%	0.0%	0.0%	-11.9%	-16.0%	-5.6%	0.03×	0.35×	0×	6.95×	0.0%	3	7.27	2	—